Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy

Figure 2

Plasma levels of different MV phenotypes in placebo (, dark grey) and TRT (, light grey) groups at baseline and after 24 weeks of treatment. Outliers are represented as filled circles.